Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2009

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 16 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders

Article in ACS Chemical Neuroscience (November 2021)

Risk assessment of therapeutic agents under consideration to treat COVID‐19 in paediatric patients and pregnant women

Article in British Journal of Clinical Pharmacology (November 2020)

Investigating the Physicochemical Stability of Highly Purified Darunavir Ethanolate Extracted from PREZISTA® Tablets

Article in AAPS PharmSciTech (June 2018)